Tisdag 26 November | 07:55:25 Europe / Stockholm

Prenumeration

Kalender

Tid*
2026-02-20 07:00 Bokslutskommuniké 2025
2025-11-07 07:00 Kvartalsrapport 2025-Q3
2025-07-25 07:00 Kvartalsrapport 2025-Q2
2025-04-25 07:00 Kvartalsrapport 2025-Q1
2025-02-21 07:00 Bokslutskommuniké 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-07-25 - Kvartalsrapport 2024-Q2
2024-06-05 - X-dag ordinarie utdelning CCC 0.00 SEK
2024-06-04 - Årsstämma
2024-05-15 - Kvartalsrapport 2024-Q1
2024-03-31 - Årsstämma
2024-02-23 - Bokslutskommuniké 2023
2023-11-10 - Kvartalsrapport 2023-Q3
2023-07-28 - Kvartalsrapport 2023-Q2
2023-06-02 - X-dag ordinarie utdelning CCC 0.00 SEK
2023-06-01 - Årsstämma
2023-04-27 - Kvartalsrapport 2023-Q1
2023-03-17 - Extra Bolagsstämma 2022
2023-02-24 - Bokslutskommuniké 2022
2022-11-30 - Kvartalsrapport 2022-Q3
2022-07-27 - Kvartalsrapport 2022-Q2
2022-05-19 - X-dag ordinarie utdelning CCC 0.00 SEK
2022-05-18 - Årsstämma
2022-04-29 - Kvartalsrapport 2022-Q1
2022-03-30 - Bokslutskommuniké 2021
2021-10-29 - Kvartalsrapport 2021-Q3
2021-07-30 - Kvartalsrapport 2021-Q2
2021-05-28 - X-dag ordinarie utdelning CCC 0.00 SEK
2021-05-27 - Årsstämma
2021-04-30 - Kvartalsrapport 2021-Q1
2021-02-26 - Bokslutskommuniké 2020
2020-10-30 - Kvartalsrapport 2020-Q3
2020-07-24 - Kvartalsrapport 2020-Q2
2020-05-14 - X-dag ordinarie utdelning CCC 0.00 SEK
2020-05-13 - Årsstämma
2020-04-30 - Kvartalsrapport 2020-Q1
2020-02-21 - Bokslutskommuniké 2019
2019-11-08 - Kvartalsrapport 2019-Q3
2019-07-31 - Kvartalsrapport 2019-Q2
2019-05-13 - X-dag ordinarie utdelning CCC 0.00 SEK
2019-05-10 - Årsstämma
2019-05-03 - Kvartalsrapport 2019-Q1
2019-02-21 - Bokslutskommuniké 2018
2018-11-02 - Kvartalsrapport 2018-Q3
2018-08-03 - Kvartalsrapport 2018-Q2
2018-05-04 - Kvartalsrapport 2018-Q1
2018-04-13 - X-dag ordinarie utdelning CCC 0.02 SEK
2018-04-12 - Årsstämma
2018-02-23 - Bokslutskommuniké 2017
2017-10-31 - Kvartalsrapport 2017-Q3
2017-08-02 - Kvartalsrapport 2017-Q2
2017-06-09 - X-dag ordinarie utdelning CCC 0.45 SEK
2017-05-03 - Kvartalsrapport 2017-Q1
2017-03-29 - Årsstämma
2017-02-22 - Bokslutskommuniké 2016
2016-11-03 - Kvartalsrapport 2016-Q3
2016-08-04 - Kvartalsrapport 2016-Q2
2016-07-01 - X-dag ordinarie utdelning CCC 0.25 SEK
2016-05-10 - Kvartalsrapport 2016-Q1
2016-04-22 - Årsstämma
2016-02-25 - Bokslutskommuniké 2015
2015-11-05 - Kvartalsrapport 2015-Q3
2015-08-05 - Kvartalsrapport 2015-Q2
2015-07-01 - X-dag ordinarie utdelning CCC 0.44 SEK
2015-05-06 - Kvartalsrapport 2015-Q1
2015-04-22 - Årsstämma
2015-02-26 - Bokslutskommuniké 2014
2014-11-06 - Kvartalsrapport 2014-Q3
2014-11-06 - Analytiker möte 2014
2014-08-07 - Kvartalsrapport 2014-Q2
2014-05-06 - Kvartalsrapport 2014-Q1
2014-04-24 - X-dag ordinarie utdelning CCC 0.36 SEK
2014-04-23 - Årsstämma
2014-02-26 - Bokslutskommuniké 2013
2013-11-07 - Kvartalsrapport 2013-Q3
2013-11-07 - Analytiker möte 2013
2013-08-08 - Kvartalsrapport 2013-Q2
2013-05-06 - Kvartalsrapport 2013-Q1
2013-04-24 - X-dag ordinarie utdelning CCC 0.35 SEK
2013-04-23 - Årsstämma
2013-02-26 - Bokslutskommuniké 2012
2012-11-12 - Kvartalsrapport 2012-Q3
2012-11-12 - Analytiker möte 2012
2012-08-09 - Kvartalsrapport 2012-Q2
2012-05-07 - Kvartalsrapport 2012-Q1
2012-05-04 - Årsstämma
2012-02-29 - Bokslutskommuniké 2011
2011-11-16 - Kvartalsrapport 2011-Q3

Beskrivning

LandSchweiz
ListaMid Cap Stockholm
SektorIndustri
IndustriIndustriprodukter
Cavotec är en industrikoncern. Inom koncernen återfinns ett brett utbud av ingenjörstjänster för sektorerna sjöfart, gruva, industri och flyg. Lösningarna innefattar strömförsörjning av kranar, rälsar, kablar och kontrollsystem. Koncernen har ett ingenjörsnätverk på global nivå och verksamhet innehas inom Europa och Nordamerika. Huvudkontoret ligger i Lugano, Schweiz.
2023-02-22 22:36:00

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, HONG KONG, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES BESIDES THOSE REQUIRED BY SWEDISH LAW. ADDITIONAL RESTRICTIONS APPLY, PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE

Cavotec SA (publ) (”Cavotec” or the ”Company”) (Nasdaq Stockholm: CCC) has successfully carried out a directed new issue of 12,452,830 shares, at a subscription price of SEK 13.25 per share, entailing raising proceeds of approximately SEK 165 million (the “Share Issue”). The subscription price was determined through an accelerated bookbuilding procedure conducted by Skandinaviska Enskilda Banken AB (”SEB”) as Sole Bookrunner. The Share Issue is subject to a subsequent resolution at an extraordinary general meeting, and a separate notice will be published within short.
 
The board of directors of Cavotec has, as indicated in the Company’s press release on 22 February 2023, resolved to proceed on a directed new issue of 12,452,830 shares, at a subscription price of SEK 13.25 per share, consequently raising proceeds of approximately SEK 165 million before transaction costs. The issue is subject to a subsequent resolution at an extraordinary general meeting to be held on 17 March 2023, and once approved, be implemented by the board of directors.
 
The purpose of the Share Issue is to increase financial flexibility to support the company to execute on its strong order book, growth plans and in addition strengthen the Company’s financial position by reducing net debt. Going forward Cavotec remains committed to leverage its market leading positions, with a strong focus on profitability and cash flows, and thereby play a vital role in the technological shift to a more sustainable world. 
 
The board of directors has carefully considered the option to carry out a rights issue in order to raise the requisite proceeds. In the evaluation, the board of directors has considered, among other things, the following factors: that a rights issue, compared to the Share Issue (i) would be significantly more time consuming, which would lead to risks that the Company loses potential growth opportunities, (ii) would entail higher total costs for the Company, mainly due to procurement of a guarantee consortium and prospectus administration etc., (iii) would expose the Company to market volatility, especially considering current market conditions, and (iv) likely would have had to be made at a lower subscription price, which may be to the disadvantage of the shareholders. Against this background, the board of director’s overall assessment is that the reasons for carrying out the Share Issue in this manner overweigh, in this particular case, the principal rule that new share issues shall be carried out with pre-emptive rights for existing shareholders, and that a new share issue with exclusion of the shareholders’ pre-emptive rights is in the interest of the Company’s shareholders.
 
To ensure that the Share Issue was carried out at market terms, the board of directors appointed SEB to conduct an accelerated bookbuilding procedure to determine the subscription price. As the subscription price was determined through an accelerated bookbuilding procedure, it is the board of directors’ assessment that the subscription price accurately reflects current market conditions and demand.
 
The Share Issue entails a dilution of approximately 11.7 percent percent of the number of shares and votes in Cavotec. The number of shares and votes in Cavotec will thereby increase by 12,452,830, from 94,014,928 to 106,467,758. The ordinary share capital in the Company will increase by CHF 8,716,981, from CHF 65,970,240 to CHF 74,687,221.
 
Extraordinary general meeting
An extraordinary general meeting will be convened on 17 March 2023 to resolve on the Share Issue. Some of the Company’s existing shareholders, including Bure Equity and Thomas von Koch together holding approximately 47 percent of the shares and votes in Cavotec, have undertaken to vote in favour thereof at the extraordinary general meeting. A separate notice to the extraordinary general meeting will be published within short.
 
Financial and legal advisors
Skandinaviska Enskilda Banken is acting as Sole Bookrunner in connection with the Share Issue. KANTER is acting as legal advisor in relation to Swedish law to Cavotec and Bär & Karrer SA is acting as legal advisors in relation to Swiss law.